93 related articles for article (PubMed ID: 29545609)
1. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
[TBL] [Abstract][Full Text] [Related]
2. Two-photon 3D FIONA of individual quantum dots in an aqueous environment.
Zhang R; Rothenberg E; Fruhwirth G; Simonson PD; Ye F; Golding I; Ng T; Lopes W; Selvin PR
Nano Lett; 2011 Oct; 11(10):4074-8. PubMed ID: 21882883
[TBL] [Abstract][Full Text] [Related]
3. 3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis.
Pérez-Treviño P; la Cerda HH; Pérez-Treviño J; Fajardo-Ramírez OR; García N; Altamirano J
Transl Oncol; 2018 Jun; 11(3):672-685. PubMed ID: 29627705
[TBL] [Abstract][Full Text] [Related]
4. 3D super-resolution imaging with blinking quantum dots.
Wang Y; Fruhwirth G; Cai E; Ng T; Selvin PR
Nano Lett; 2013 Nov; 13(11):5233-41. PubMed ID: 24093439
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of nanobody sequence and structure data.
Mitchell LS; Colwell LJ
Proteins; 2018 Jul; 86(7):697-706. PubMed ID: 29569425
[TBL] [Abstract][Full Text] [Related]
6. Selectable high-yield recombinant protein production in human cells using a GFP/YFP nanobody affinity support.
Schellenberg MJ; Petrovich RM; Malone CC; Williams RS
Protein Sci; 2018 Jun; 27(6):1083-1092. PubMed ID: 29577475
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
[TBL] [Abstract][Full Text] [Related]
8. Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity.
Menzel S; Schwarz N; Haag F; Koch-Nolte F
Front Pharmacol; 2018; 9():266. PubMed ID: 29636685
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial Design of a Nanobody that Specifically Targets Structured RNAs.
Cawez F; Duray E; Hu Y; Vandenameele J; Romão E; Vincke C; Dumoulin M; Galleni M; Muyldermans S; Vandevenne M
J Mol Biol; 2018 May; 430(11):1652-1670. PubMed ID: 29654796
[TBL] [Abstract][Full Text] [Related]
11. Modulating ion channel function with antibodies and nanobodies.
Stortelers C; Pinto-Espinoza C; Van Hoorick D; Koch-Nolte F
Curr Opin Immunol; 2018 Jun; 52():18-26. PubMed ID: 29579624
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer.
Montemagno C; Bacot S; Ahmadi M; Kerfelec B; Baty D; Debiossat M; Soubies A; Perret P; Riou L; Fagret D; Broisat A; Ghezzi C
J Nucl Med; 2018 Jul; 59(7):1056-1062. PubMed ID: 29572256
[TBL] [Abstract][Full Text] [Related]
13. Binding Specificities of Nanobody•Membrane Protein Complexes Obtained from Chemical Cross-Linking and High-Mass MALDI Mass Spectrometry.
Köhler M; Neff C; Perez C; Brunner C; Pardon E; Steyaert J; Schneider G; Locher KP; Zenobi R
Anal Chem; 2018 Apr; 90(8):5306-5313. PubMed ID: 29562137
[TBL] [Abstract][Full Text] [Related]
14. Applications of nanobodies in plant science and biotechnology.
Wang W; Yuan J; Jiang C
Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
[TBL] [Abstract][Full Text] [Related]
15. Recombinant expression of nanobodies and nanobody-derived immunoreagents.
de Marco A
Protein Expr Purif; 2020 Aug; 172():105645. PubMed ID: 32289357
[TBL] [Abstract][Full Text] [Related]
16. Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants.
Xu J; Xu K; Jung S; Conte A; Lieberman J; Muecksch F; Cetrulo Lorenzi JC; Park S; Wang Z; Tessarollo L; Bylund T; Chuang GY; Olia AS; Stephens T; Teng IT; Tsybovsky Y; Zhou T; Hatziioannou T; Bieniasz PD; Nussenzweig MC; Kwong PD; Casellas R
bioRxiv; 2021 Mar; ():. PubMed ID: 33688659
[TBL] [Abstract][Full Text] [Related]
17. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.
Altunay B; Morgenroth A; Beheshti M; Vogg A; Wong NCL; Ting HH; Biersack HJ; Stickeler E; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1371-1389. PubMed ID: 33179151
[TBL] [Abstract][Full Text] [Related]
18. Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation.
Bridoux J; Broos K; Lecocq Q; Debie P; Martin C; Ballet S; Raes G; Neyt S; Vanhove C; Breckpot K; Devoogdt N; Caveliers V; Keyaerts M; Xavier C
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33003481
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix.
Jailkhani N; Ingram JR; Rashidian M; Rickelt S; Tian C; Mak H; Jiang Z; Ploegh HL; Hynes RO
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14181-14190. PubMed ID: 31068469
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
